Report cover image

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18750351

Description

Global Paroxysmal Nocturnal Hemoglobinuria Treatment Databank Market Report


The Paroxysmal Nocturnal Hemoglobinuria Treatment market was valued at $2,416.8 Million in 2022, and is projected to reach $5,187.1 Million by 2031 growing at a CAGR of 8.91% from 2023 to 2031. Medication segment is expected to be the highest contributor to this market, with $1,914.4 Million in 2022, and is anticipated to reach $4,028.1 Million by 2031, registering a CAGR of 8.67%. Stem Cell Transplant segment is anticipated to reach $1,107.9 Million by 2031 with the highest CAGR of 9.85%. Medication and Stem Cell Transplant segments collectively expected to account for about 99.0% share of the Paroxysmal Nocturnal Hemoglobinuria Treatment market in 2022, with the former constituting around 79.2% share. Stem Cell Transplant and Medication segments are expected to witness significant growth rates at a CAGR of 9.85% and 8.67% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 99.0% in the overall Paroxysmal Nocturnal Hemoglobinuria Treatment market in 2022, and is anticipated to reach 99.0% by 2031.

Table of Contents

100 Pages
1. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
1.1. Overview
1.2. Medication
1.2.1 Medication Market, By Region
1.2.1.1 North America Medication Market, By Country
1.2.1.2 Europe Medication Market, By Country
1.2.1.3 Asia-Pacific Medication Market, By Country
1.2.1.4 Rest of World Medication Market, By Country
1.3. Stem Cell Transplant
1.3.1 Stem Cell Transplant Market, By Region
1.3.1.1 North America Stem Cell Transplant Market, By Country
1.3.1.2 Europe Stem Cell Transplant Market, By Country
1.3.1.3 Asia-Pacific Stem Cell Transplant Market, By Country
1.3.1.4 Rest of World Stem Cell Transplant Market, By Country
1.4. Blood Transfusion
1.4.1 Blood Transfusion Market, By Region
1.4.1.1 North America Blood Transfusion Market, By Country
1.4.1.2 Europe Blood Transfusion Market, By Country
1.4.1.3 Asia-Pacific Blood Transfusion Market, By Country
1.4.1.4 Rest of World Blood Transfusion Market, By Country
2. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Region
2.1. Overview
2.2. North America
2.2.1 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.2.2 North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Country
2.2.2.1 U.S.
2.2.2.1.1 U.S. Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.2.2.2 Canada
2.2.2.2.1 Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3. Europe
2.3.1 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3.2 Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Country
2.3.2.1 Germany
2.3.2.1.1 Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3.2.2 U.K.
2.3.2.2.1 U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3.2.3 France
2.3.2.3.1 France Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3.2.4 Italy
2.3.2.4.1 Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3.2.5 Spain
2.3.2.5.1 Spain Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.3.2.6 Rest of Europe
2.3.2.6.1 Rest of Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.4. Asia-Pacific
2.4.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.4.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Country
2.4.2.1 China
2.4.2.1.1 China Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.4.2.2 Japan
2.4.2.2.1 Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.4.2.3 Rest of Asia
2.4.2.3.1 Rest of Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.5. Rest of World
2.5.1 Rest of World Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.5.2 Rest of World Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Country
2.5.2.1 South Africa
2.5.2.1.1 South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.5.2.2 Australia
2.5.2.2.1 Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
2.5.2.3 ROW Countries
2.5.2.3.1 ROW Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market, By Treatment
ROW Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD LIST OF TABLES
TABLE 1. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 2. Medication Market Value, By Region, 2022-2031, Million USD
TABLE 3. North America Medication Market Value, By Country, 2022-2031, Million USD
TABLE 4. Europe Medication Market Value, By Country, 2022-2031, Million USD
TABLE 5. Asia-Pacific Medication Market Value, By Country, 2022-2031, Million USD
TABLE 6. Rest of World Medication Market Value, By Country, 2022-2031, Million USD
TABLE 7. Stem Cell Transplant Market Value, By Region, 2022-2031, Million USD
TABLE 8. North America Stem Cell Transplant Market Value, By Country, 2022-2031, Million USD
TABLE 9. Europe Stem Cell Transplant Market Value, By Country, 2022-2031, Million USD
TABLE 10. Asia-Pacific Stem Cell Transplant Market Value, By Country, 2022-2031, Million USD
TABLE 11. Rest of World Stem Cell Transplant Market Value, By Country, 2022-2031, Million USD
TABLE 12. Blood Transfusion Market Value, By Region, 2022-2031, Million USD
TABLE 13. North America Blood Transfusion Market Value, By Country, 2022-2031, Million USD
TABLE 14. Europe Blood Transfusion Market Value, By Country, 2022-2031, Million USD
TABLE 15. Asia-Pacific Blood Transfusion Market Value, By Country, 2022-2031, Million USD
TABLE 16. Rest of World Blood Transfusion Market Value, By Country, 2022-2031, Million USD
TABLE 17. Global Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Region, 2022-2031, Million USD
TABLE 18. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 19. North America Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 20. U.S. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 21. Canada Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 22. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 23. Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 24. Germany Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 25. U.K. Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 26. France Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 27. Italy Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 28. Spain Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 29. Rest of Europe Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 30. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 31. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 32. China Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 33. Japan Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 34. Rest of Asia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 35. Rest of World Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 36. Rest of World Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Country, 2022-2031, Million USD
TABLE 37. South Africa Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 38. Australia Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
TABLE 39. ROW Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD
ROW Countries Paroxysmal Nocturnal Hemoglobinuria Treatment Market Value, By Treatment, 2022-2031, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us